Akron Parentarals Private Limited

Akron Parentarals Private Limited - pharma in Muppalla, Andhra Pradesh, India. FY 2026 financials & compliance.
CIN U24239AP1994PTC016773 Incorporated 04 January 1994 ROC Vijayawada HQ Muppalla, Andhra Pradesh, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹25.9 Cr
▲ 26% YoY
Net profit · FY 2025
₹1.08 Cr
Net margin 4.2%
EBITDA · FY 2025
₹4.59 Cr
EBITDA margin 17.7%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹9.99 Cr
Issued & subscribed
Open charges
₹14.01 Cr
Satisfied ₹1.43 Cr
Company age
32 yrs
Est. 1994
Employees · EPFO
94
Provident fund records

About Akron Parentarals Private Limited

Data last updated:

Akron Parentarals Private Limited is a private limited company based in Muppalla, Andhra Pradesh, India, a subsidiary of Pranaya Pharmaceuticals Private Limited. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 04 January 1994 and has been in existence for over 32 years.

The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24239AP1994PTC016773. Its GSTIN is 37AADCS1197A1ZK (Andhra Pradesh).

The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.99 Cr. It was formerly known as Safe Parentarals Ltd. It is led by directors including Kumaraswamy Reddy Maruri and Sivaramakrishnareddy Pathuri.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Muppalla, Andhra Pradesh.

As per the financials filed for FY 2025, the company reported a revenue of ₹25.9 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹1.08 Cr (net margin 4.2%) and EBITDA of ₹4.59 Cr (EBITDA margin 17.7%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 29% over five years.

The company has about 94 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹14.01 Cr and satisfied charges of ₹1.43 Cr on record.

Akron Parentarals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-04-0001854). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pranayagroup.com.

Company Details of Akron Parentarals Private Limited
CIN U24239AP1994PTC016773
Registration Number 016773
Incorporation Date 04 January 1994
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Pranaya Pharmaceuticals Private Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-AP-04-0001854

CIN History of Akron Parentarals Private Limited

Akron Parentarals has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24239AP1994PTC016773, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239AP1994PTC016773Current
L24239AP1994PLC016773Previous
U24239AP1994PLC016773Previous

Recognitions & Rankings of Akron Parentarals

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-AP-04-0001854
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    9/2/36/A Sattenapalli Road, Gollapadu, Muppalla, Andhra Pradesh, India – 522408
  • Industry
    Pharma, Animal Pharmaceuticals & Healthcare
Comprehensive company report
Akron Parentarals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Akron Parentarals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Akron Parentarals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Akron Parentarals Private Limited

The main business activity of Akron Parentarals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Akron Parentarals Private Limited FY 2025 filings available

Akron Parentarals Private Limited reported revenue of ₹25.9 Cr (up 26% YoY) for FY 2025.

Revenue · FY 2025
₹25.9 Cr ▲ 26%
Net profit · FY 2025
₹1.08 Cr margin 4.2%
EBITDA · FY 2025
₹4.59 Cr margin 17.7%

Compounded Annual Growth Rate (CAGR) of Akron Parentarals Private Limited

Revenue CAGR growth
1 year
▲ 26%
3 years · compounded
▼ 6%
5 years · compounded
▲ 29%
EBITDA CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 9%
5 years · compounded
▲ 92%

Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 26% growth in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Akron Parentarals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations₹25.9 Cr••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹4.59 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹1.08 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Akron Parentarals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin17.7%••••••••••••••••
Net Profit Margin4.2%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Akron Parentarals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Akron Parentarals Private Limited

Akron Parentarals has 3 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kumaraswamy Reddy MaruriDirector22 May 20233 Years 4 MonthsCurrent
Sivaramakrishnareddy PathuriDirector04 Jan 20242 Years 9 MonthsCurrent
Satyanarayana ReddyDirector04 Jan 20242 Years 9 MonthsCurrent

Peer Comparison of Akron Parentarals Private Limited

Akron Parentarals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Animal Pharma). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Prashanti Formulations Limited₹29.89 Cr (FY 2025)••••••••-26.0%••••Hoshiarpur, Punjab, India
Le-Mantus Pharmaceuticals Private Limited₹29.31 Cr (FY 2024)••••••••-27.0%••••Delhi, India
Goel Vet Pharma Private Limited₹28.84 Cr (FY 2024)••••••••-7.0%••••Chittorgarh, Rajasthan, India
Adisan Laboratories Private Limited₹27.53 Cr (FY 2025)••••••••4.0%••••Mulshi, Maharashtra, India
Healthy Biosciences Limited₹27.32 Cr (FY 2025)••••••••61.0%••••Mohali, Punjab, India
Akron Parentarals Private Limited this company₹25.9 Cr (FY 2025)••••••••26.0%••••Muppalla, Andhra Pradesh, India
Bushal Chemi-Pharma Private Limited₹25.58 Cr (FY 2025)••••••••3.0%••••Badlapur, Maharashtra, India
S.G. Vet Care Private Limited₹24.28 Cr (FY 2025)••••••••-6.0%••••Gandhinagar, Gujarat, India
Indian Genomix Private Limited₹23.72 Cr (FY 2025)••••••••6.0%••••Hyderabad, Telangana, India
Gentle Bio-Sciences Private Limited₹23.7 Cr (FY 2024)••••••••-12.0%••••Hyderabad, Telangana, India
Vibro Pharma Private Limited₹23.45 Cr (FY 2025)••••••••4.0%••••Mumbai, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Akron Parentarals by revenue in the Pharma industry (Animal Pharma), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Akron Parentarals Private Limited

Akron Parentarals Private Limited is audited by VASANTHA RAO & ASSOCIATES for the financial year 2024.

NameStatusAppointment DateCessation Date
VASANTHA RAO & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Akron Parentarals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Akron Parentarals Private Limited

Open charges
₹14.01 Cr
Satisfied charges
₹1.43 Cr
Breakdown by lending institutions
Indian Bank₹14.01 Cr
Latest charge details
DateLenderAmountStatus
16 Apr 2010Indian Bank₹14.01 CrOpen
27 Mar 2004Uco Bank₹40 LakhSatisfied
25 Sep 1995State Bank of India₹34.5 LakhSatisfied
22 Mar 1995State Bank of India₹68 LakhSatisfied

Total charge records: 4 View all charges

Employees and EPFO Compliance at Akron Parentarals Private Limited

Akron Parentarals Private Limited has a workforce of 94 employees as of Apr 08, 2024.

Employee count
94
Active EPFO establishments
1
Employee growth
-11.32%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Akron Parentarals Private Limited

Akron Parentarals Private Limited has 20 board changes on record since 2009: 3 appointments and 17 cessations. The latest: Satyanarayana Reddy ceased to be Additional Director on 29 Sep 2024.

Charges
A charge with Indian Bank of Rs. 14.01 Cr registered on 16 Apr 2010 with Charge ID 10214554 was modified on 01 Dec 2025.
AGM
Akron Parentarals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Akron Parentarals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada.
Ceased
Satyanarayana Reddy ceased to be Additional Director.
Ceased
Sivaramakrishnareddy Pathuri ceased to be Additional Director.
Appointed
Satyanarayana Reddy was appointed as Director.
Appointed
Sivaramakrishnareddy Pathuri was appointed as Director.
Ceased
Kumaraswamy Reddy Maruri ceased to be Additional Director.
Appointed
Kumaraswamy Reddy Maruri was appointed as Director.
Ceased
Balineni Aruna ceased to be Additional Director.
Ceased
Govinda Reddy Balineni ceased to be Additional Director.
Ceased
Anji Reddy Tatiparthi ceased to be Additional Director.

19 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Akron Parentarals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Akron Parentarals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Akron Parentarals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Akron Parentarals Private Limited

Akron Parentarals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
37AADCS1197A1ZKAndhra PradeshActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Akron Parentarals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akron Parentarals Private Limited

Akron Parentarals is an active private limited company based in Muppalla, Andhra Pradesh, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 04 January 1994 (32+ years old) and is registered under CIN U24239AP1994PTC016773.

Akron Parentarals reported revenue of ₹25.9 Cr for FY 2025 (up 26% YoY).

Akron Parentarals has 3 current directors:

Akron Parentarals reported a net profit of ₹1.08 Cr (net margin 4.2%) and EBITDA of ₹4.59 Cr (EBITDA margin 17.7%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Akron Parentarals is -6% over three years and 29% over five years. In the latest year (FY 2025) revenue rose 26%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Akron Parentarals is 37AADCS1197A1ZK, registered in Andhra Pradesh.

The CIN (Corporate Identification Number) of Akron Parentarals is U24239AP1994PTC016773. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Akron Parentarals was incorporated on 04 January 1994, making it 32+ years old. It is registered with the Registrar of Companies, Vijayawada.

The peers of Akron Parentarals by revenue are Prashanti Formulations Limited, Le-Mantus Pharmaceuticals Private Limited, Goel Vet Pharma Private Limited, Adisan Laboratories Private Limited, Healthy Biosciences Limited and 5 more, all in the Pharma industry (Animal Pharma).

Satyanarayana Reddy ceased to be Additional Director on 29 Sep 2024. Sivaramakrishnareddy Pathuri ceased to be Additional Director on 29 Sep 2024. Satyanarayana Reddy was appointed as Director on 04 Jan 2024. Akron Parentarals has 20 board changes on record in total.

Yes, Akron Parentarals is registered as a small enterprise under Udyam registration (number: UDYAM-AP-04-0001854).

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available